POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study

Digna T. de Bruin, Manon A. A. Jansen, Diana R. Pereira, Lisa van Schijndel, Erica S. Klaassen, Marije E. Otto, Jeremy Skillington, Paula Maguire, Liam Tremble, Alan Bell, Laura Maher, Katsuhiro Mihara, Mark Sumeray, Derek W. Gilroy, Naomi B. Klarenbeek, Matthijs Moerland · 2026

Read POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study by Digna T. de Bruin, Manon A. A. Jansen, Diana R. Pereira, Lisa van Schijndel, Erica S. Klaassen, Marije E. Otto, Jeremy Skillington, Paula Maguire, Liam Tremble, Alan Bell, Laura Maher, Katsuhiro Mihara, Mark Sumeray, Derek W. Gilroy, Naomi B. Klarenbeek, Matthijs Moerland (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12877788.txt.

Description

Digna de Bruin and co-authors tested an oral drug meant to calm inflammation in healthy volunteers. The drug, POLB 001, blocks a signaling protein called p38 MAPK and is being developed to prevent the immune overreaction that cancer immunotherapy can trigger. Volunteers took the drug or a placebo twice a day for seven days.

On day four a bacterial toxin was injected into the skin, and on day six into a vein. The drug cut the local immune cell influx sharply, by up to four-fifths for some cell types, and lowered key inflammatory signals in the blood by as much as four-fifths as well. It also blunted the heart rate rise after the vein dose. The drug was well tolerated, and the authors say it works as designed in the body.

Catalog record

CREATORDigna T. de Bruin, Manon A. A. Jansen, Diana R. Pereira, Lisa van Schijndel, Erica S. Klaassen, Marije E. Otto, Jeremy Skillington, Paula Maguire, Liam Tremble, Alan Bell, Laura Maher, Katsuhiro Mihara, Mark Sumeray, Derek W. Gilroy, Naomi B. Klarenbeek, Matthijs Moerland
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE33 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12877788

Browse the full library · About the Tower of Babel